"Kleinwachau ist eine gemeinnützige diakonische Einrichtung. Wir behandeln und betreuen Menschen mit Epilepsie und Menschen mit Behinderungen – ambulant und stationär. Wir beraten, behandeln, fördern, assistieren, pflegen, lehren und lernen, leben und arbeiten miteinander. Grundlage unserer Arbeit ist das christliche Menschenbild. Seinen Ausdruck findet es im diakonischen Profil unserer Einrichtung. Unsere Bewohner, Patienten, Werkstattbeschäftigten und Schüler nutzen moderne Möglichkeiten für Wohnen, Therapie, Arbeit und Unterricht, die ihren jeweiligen Lebensbedürfnissen entsprechen. Unsere Arbeit zeichnet sich durch Fachlichkeit und Engagement aus."

During the past decade, Kleinwachau, Sächsisches Epilepsiezentrum Radeberg conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kleinwachau, Sächsisches Epilepsiezentrum Radeberg" #1 collaborator was "Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kleinwachau, Sächsisches Epilepsiezentrum Radeberg" are "Dravet Syndrome" (2 trials), "Dravet Syndrome (DS)" (1 trials), "Epileptic Encephalopathy" (1 trials), "Lennox Gastaut Syndrome" (1 trials) and "Lennox Gastaut Syndrome (LGS)" (1 trials). Many other conditions were trialed in "Kleinwachau, Sächsisches Epilepsiezentrum Radeberg" in a lesser frequency.

Most popular intervention types in "Kleinwachau, Sächsisches Epilepsiezentrum Radeberg" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Soticlestat" (2 trials), "ZX008 (Fenfluramine Hydrochloride)" (2 trials), "ACT-709478 for oral use" (1 trials) and "Matching Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kleinwachau, Sächsisches Epilepsiezentrum Radeberg" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Kleinwachau, Sächsisches Epilepsiezentrum Radeberg". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kleinwachau, Sächsisches Epilepsiezentrum Radeberg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kleinwachau, Sächsisches Epilepsiezentrum Radeberg, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".